biopharm

Dialectic Therapeutics cancer

Fort Worth Biopharma Actuate Therapeutics Raises $21.7M in Series B Funding

by | May 20, 2019
The company said it will use the funding to expand its ongoing Phase 1 / 2 clinical trial and fund development programs.
MORE